Following the British HIV Association’s (BHIVA) proposal of ambitious targets for eliminating hepatitis C in people living with HIV in the UK, a new editorial in The Lancet looks at some the benefits of microelimination strategies.
“Focusing elimination efforts in smaller affected populations allows for quick, efficient targeting of treatment and prevention services,” the article reads.
“Microelimination strategies can help build momentum where logistic and political challenges hamper national plans for elimination. Microelimination could have a knock-on effect on new infections with fewer people able to transmit HCV.”
Read the full article in The Lancet HIV here.
Image “HIV and Hepatitis Test” by Victor is licensed under CC BY 2.0.